Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy (DMD) is a severe, progressive X-linked recessive neuromuscular disorder characterized by the absence of functional dystrophin protein, leading to systematic skeletal muscle degeneration and cardiomyopathy.

DMD is caused by mutations (typically deletions or duplications) in the DMD gene on the X chromosome (Xp21.2), which encodes the protein dystrophin. Approximately one-third of cases arise from de novo mutations.

Dystrophin acts as a structural bridge between the actin cytoskeleton and the extracellular matrix. Its absence leads to sarcolemmal fragility, calcium influx, mitochondrial dysfunction, chronic inflammation, and subsequent replacement of muscle tissue with fibrous and adipose connective tissue.

DMD affects approximately 1 in 3,500 to 5,000 live male births. It is primarily an X-linked disorder, though female carriers may exhibit mild symptoms (manifesting carriers).

• Family history of DMD or Becker muscular dystrophy.
• Male biological sex.
• Maternal carrier status.

A. Early Symptoms

• Delayed motor milestones (walking).


• Frequent falls.


• Difficulty climbing stairs. B. Common Symptoms


• Gowers’ sign (using hands to "walk up" legs to stand).


• Proximal muscle weakness.


• Calf pseudohypertrophy.


• Toe walking. C. Advanced Symptoms


• Loss of ambulation (typically age 10-12).


• Scoliosis.


• Contractures.


• Respiratory insufficiency. D. Emergency Symptoms


• Acute respiratory distress.


• Unexplained arrhythmias or chest pain.

• Proximal muscle wasting.
• Lumbar lordosis.
• Calf pseudohypertrophy (fat/fibrous infiltration).
• Diminished deep tendon reflexes.

A. Clinical Assessment: History of motor delay and physical exam.
B. Laboratory Testing: Elevated Serum Creatine Kinase (CK).
C. Imaging Studies: Muscle MRI to assess fatty replacement.
D. Functional Tests: 6-minute walk test (6MWT).
E. Biopsy Findings: Dystrophin protein deficiency.
F. Genetic Testing: Multiplex ligation-dependent probe amplification (MLPA).
G. Differential Diagnosis: Becker muscular dystrophy, Spinal Muscular Atrophy, Limb-Girdle Muscular Dystrophy.

Creatine Kinase (CK)
Type: Blood Test
Purpose: Screen for muscle cell membrane damage
Expected Findings: Extremely elevated (10–100x normal)
Interpretation: Indicative of myopathy

Muscle MRI
Purpose: Quantify muscle fat infiltration and inflammation
Typical Findings: Increased signal intensity on T1-weighted images
Importance: Tracks disease progression and therapeutic efficacy

• Becker Muscular Dystrophy (milder phenotype).
• Limb-Girdle Muscular Dystrophy (later onset).
• Polymyositis (acquired inflammatory).

Dilated cardiomyopathy, restrictive lung disease, kyphoscoliosis, and joint contractures.

A. Lifestyle Modifications: Balanced diet, physical activity.
B. Preventive Measures: Vaccination against influenza/pneumococcal disease.
C. Medical Treatment

• Corticosteroids (Deflazacort, Prednisone): Reduce inflammation.


• Exon-skipping therapies (Eteplirsen): Modulate mRNA splicing.

Life expectancy is typically into the late 20s or 30s with modern respiratory and cardiac care.

Genetic counseling and prenatal diagnosis for known carrier mothers.

The following homeopathic remedies have been historically indicated for symptoms associated with Duchenne Muscular Dystrophy. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Duchenne Muscular Dystrophy.